Mss Meditechno (India) Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 15-11-2024
- Paid Up Capital ₹ 7.50 M
as on 15-11-2024
- Company Age 9 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.23 Cr
as on 15-11-2024
- Revenue 78.03%
(FY 2023)
- Profit 164.02%
(FY 2023)
- Ebitda 214.04%
(FY 2023)
- Net Worth 39.04%
(FY 2023)
- Total Assets 11.28%
(FY 2023)
About Mss Meditechno (India)
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹10.23 Cr.
Mit Sharma, Bhavin Sharma, and Purshottam Sharma serve as directors at the Company.
- CIN/LLPIN
U33110GJ2015PTC085336
- Company No.
085336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mss Meditechno (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mit Sharma  | Director | 10-Dec-2015 | Current |
| Bhavin Sharma | Director | 10-Dec-2015 | Current |
| Purshottam Sharma | Director | 10-Dec-2015 | Current |
Financial Performance of Mss Meditechno (India).
Mss Meditechno (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.03% increase. The company also saw a substantial improvement in profitability, with a 164.02% increase in profit. The company's net worth Soared by an impressive increase of 39.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mss Meditechno (India)?
In 2023, Mss Meditechno (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Khadka-G Automobiles Private LimitedActive 8 years 11 monthsMit Sharma, Bhavin Sharma and 1 more are mutual person
- Natraj Autolink Private LimitedActive 3 years 8 months
Mit Sharma, Bhavin Sharma and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Apr 2023 | ₹2.48 M | Open |
State Bank Of India Creation Date: 04 Jan 2018 | ₹9.98 Cr | Open |
How Many Employees Work at Mss Meditechno (India)?
Unlock and access historical data on people associated with Mss Meditechno (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mss Meditechno (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mss Meditechno (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
